Status:
COMPLETED
Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide
Lead Sponsor:
Qianfoshan Hospital
Conditions:
Multiple Myeloma
Myelodysplastic Syndromes
Eligibility:
All Genders
18+ years
Brief Summary
This is a non-intervention, prospective, open-label and observational clinical trial. The researchers plan to recruit at least 50 qualified patients. The main purpose of this study was to establish a ...
Detailed Description
Studies have found that there is significant interpatient variability in the plasma concentration of lenalidomide, and the PK parameters of lenalidomide do not affect its efficacy but may be correlate...
Eligibility Criteria
Inclusion
- Patients who are above the age of 18
- Patients who receive lenalidomide treatment
Exclusion
- Patients have received other investigational systemic drugs
- The clinical data are deemed insufficient
- There appear other factors that rendered them ineligible.
Key Trial Info
Start Date :
October 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT06069024
Start Date
October 15 2021
End Date
May 31 2023
Last Update
April 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the First Affiliated Hospital of Shandong First Medical University
Jinan, Shandong, China